Researchers discover how cancer cells remain invisible to the immune system
Researchers at the University of British Columbia have discovered how [...]
European Commission approves Kisplyx (lenvatinib) for advanced kidney cancer
The European Commission has approved Kisplyx (lenvatinib) for the treatment [...]
EU approves Cabometyx (cabozantinib) for advanced kidney cancer
The European Medicines Agency (EMA) has approved Cabometyx (cabozantinib) as [...]
VEGF/mTOR combination for non-clear cell kidney cancer
The combination of vascular endothelial growth factor (VEGF)-directed and mammalian [...]
Overweight people fare better with kidney cancer
It is well known that obesity is a risk factor [...]
New class of kidney cancer drugs potentially more effective than sunitinib
A recent pre-clinical study published in the journal Nature shows that [...]
Clinical trial of tivozanib plus nivolumab combination
Tivozanib, a VEGF tyrosine kinase inhibitor, is to be combined [...]
NHS patients missing out on cancer drugs
New research published by charities Breast Cancer Now and Prostate [...]
